1. Gavras S, Drake MJ, Gratzke C, Madersbacher C, Tikkinen KAO, Mamoulakis C, Bach T, Gacci M, Herrmann TRW, Karavitakis M, Malde S, Sakalis V, Umbach R (2015) European Association of Urology. Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS) including benign prostate obstruction (BPO). https://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdf
2. Lai S, Peng P, Diao T, Hou H, Wang X, Zhang W, Liu M, Zhang Y, Seery S, Wang J (2019) Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies. BMJ Open. https://doi.org/10.1136/bmjopen-2018-028855
3. Hueber PA, Ben-Zvi T, Liberman D, Bhojani N, Gautam G, Deklaj T, Katz M, Zorn KC (2012) Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes <60 cc, 60 cc-100 cc and >100 cc. Can J Urol 19(5):6450–6458
4. Valdivieso R, Hueber PA, Meskawi M, Belleville E, Ajib K, Bruyere F, Te AE, Chughtai B, Elterman D, Misrai V, Zorn KC (2018) Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostates. BJU Int 122(5):873–878. https://doi.org/10.1111/bju.14208
5. Elshal AM, Elmansy HM, Elhilali MM (2013) Two laser ablation techniques for a prostate less than 60 mL: lessons learned 70 months after a randomized controlled trial. Urology 82(2):416–422. https://doi.org/10.1016/j.urology.2013.02.074